Rocket Lab
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Its last 4 Sell calls were followed by a 29% average decline over the next quarter.
- Recent price momentum is -11.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 7.4% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability D
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 34.4% | Better than 39% |
| Operating margin | -38.0% | Better than 10% |
| Net margin | -32.9% | Better than 10% |
| Return on equity | -18.8% | Better than 16% |
| Return on invested capital | -14.0% | Better than 16% |
Momentum D+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -37.4% | Better than 12% |
| 6-month return | -66.5% | Better than 3% |
| 12-month return (ex latest month) | 30.5% | Better than 70% |
| Distance below 52-week high | 69.9% | Better than 6% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.1x | Better than 81% |
| Debt to assets | 10.9% | Better than 68% |
| Interest coverage | -7.5x | Better than 14% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 88.2% | Better than 71% |
| Upside to average target | 115.2% | Better than 87% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 50.99
- Open
- 49.75
- Day range
- 45.11 - 50.68
- Avg price
- 46.97
- Volume
- 21.55M
- Turnover
- 1.01B
- Turnover ratei
- 3.65%
- Volume ratioi
- 1.47
- Amplitudei
- 10.92%
- 52-week rangei
- 39.30 - 151.00
Valuation
- P/Ei
- -122.76
- P/E (TTM)i
- -122.76
- P/Bi
- 4.95
- EPSi
- -0.37
- Book value / shi
- 9.18
- Net profit
- -233.85M
- Net assets
- 5.80B
Share structure
- Market cap
- 28.71B
- Float capi
- 26.82B
- Shares out
- 632.02M
- Float sharesi
- 590.51M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
69.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-324.93M net over the window
Short interest
- Shares short
- 46.41M
- % of floati
- 7.39%
- Days to coveri
- 2.83
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Rocket Lab (RKLB)?
Rocket Lab last traded at 45.42. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Rocket Lab's market cap?
About 28.71B.
What is the P/E ratio of Rocket Lab?
The trailing twelve-month P/E is -122.76. The Valuation tab shows it against the stock's own five-year range.
Does Rocket Lab pay a dividend?
Rocket Lab does not currently pay a regular dividend.
Is Rocket Lab a buy according to analysts?
The consensus of 17 analysts is a Buy rating, with an average 12-month price target of 97.75, which implies 115.2% upside from the current price. This is not investment advice.
What is Rocket Lab's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Rocket Lab a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:59:55 · For reference only, not investment advice and not tailored to your situation.
Rocket Lab discussion 0 comments